C

Codexis, Inc.

294 employees

Codexis is a biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics.

Investor insights

Sectors invested in

Biotechnology3
CAR-T Therapy2
Genetics2
Health Care2
Diagnostics2
DNA Data Storage2
Cell Therapies2
Vaccines2
Cell Therapy2
DNA2
Genetic Medicines2
SynBio2
DNA Synthesis2
Gene Editin2
AgBio2
Synthetic Biology2
CRISPR2
Enzymatic DNA Synthesis2
Life Science1
SARS-CoV-2 Surveillance1

Funding rounds participated in

$12M sweet spot round size

Most of their 3 investments are in rounds between $7M and $12M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Industrial Enzymes
Oligo synthesis
Biocatalysis
Genomics
Pharmaceutical manufacturing
Enzyme Engineering
Biocatalysts
Sustainable chemicals for household & personal care products
Life Sciences
Directed Evolution
Chemical
RNA manufacturing
Enzyme replacement therapy
RNA detection
Sustainability
Renewable Products
Gene therapy
API manufacturing
Enzyme Optimization

Date founded

2002

Investments made

s

seqWell raised $7M on March 29, 2022

Investors: Research Corporation Technologies, Inc., BroadOak Capital Partners and Codexis, Inc.

M

Molecular Assemblies, Inc. raised $26M on March 15, 2022

Investors: LYFE Capital, Casdin Capital, LLC, Argonautic Ventures, iSelect Fund and Codexis, Inc.

M

Molecular Assemblies, Inc. raised $12M on April 15, 2021

Investors: LYFE Capital, iSelect Fund, Argonautic Ventures and Codexis, Inc.

Funding rounds raised

Total raised

$50M

from 3 investors over 3 rounds

C

Codexis, Inc. raised $50M on June 20, 2019

Investors: Casdin Capital, LLC

C

Codexis, Inc. raised $37M on August 14, 2006

Investors: CMEA Capital and EDBI Pte Ltd

FAQ